Related Experiment Video
Updated: Aug 8, 2026
08:30
Operant Procedures for Assessing Behavioral Flexibility in Rats
Published on: February 15, 2015
Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists
Matthew N Hill1, Larissa M Froese, Anna C Morrish
1Department of Psychology and the Brain Research Centre, University of British Columbia, Vancouver, V6T1Z4, BC, Canada .
Psychopharmacology
|June 6, 2006
Summary
The cannabinoid CB1 receptor system plays a complex role in behavioral flexibility. Activating or blocking these receptors influences rats' ability to adapt to changing rules, suggesting therapeutic potential for cognitive disorders.
Area of Science:
- Neuroscience
- Behavioral Pharmacology
- Cognitive Science
Background:
- Cannabinoid CB1 receptors are present in the prefrontal cortex.
- Their precise function in executive functions like behavioral flexibility remains largely unknown.
Purpose of the Study:
- To investigate the impact of cannabinoid CB1 receptor modulation on behavioral flexibility.
- Utilized a strategy set-shifting task in a cross maze to assess these effects.
Main Methods:
- Rats were trained on a discrimination task, then tested on their ability to shift strategies.
- Pharmacological agents targeting CB1 receptors (HU-210 agonist, AM251 antagonist) were administered.
Main Results:
- The CB1 agonist HU-210 demonstrated dose-dependent effects, increasing perseverative errors at higher doses.
- The CB1 antagonist AM251 reduced perseverative errors, indicating a facilitatory role of CB1 in cognitive flexibility.
Conclusions:
- The cannabinoid system exhibits a biphasic, dose-sensitive influence on behavioral flexibility.
- Findings suggest potential clinical relevance for the endocannabinoid system in psychiatric conditions characterized by impaired cognitive flexibility.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:24Operant Conditioning Intervention
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...